NuGenerex
IMMUNO-ONCOLOGY
AE37 immunotherapeutic vaccine for Breast, Prostate, Bladder
NuGenerex
HEALTH
Ancillary health management services for chronic conditions
NuGenerex
REGENERATIVE
Olaregen Therapeutix, Regentys
NuGenerex
DIAGNOSTICS
NGDx Express II rapid diagnostic tests for infectious disease
NuGenerex
THERAPEUTICS
Oral-lyn (Buccal Insulin) and RapidMist Buccal delivery technology
WELCOME TO GENEREX BIOTECHNOLOGY
Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians and ongoing relationships with patients to improve the patient experience and access to optimal care.
In addition to advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics, the Company is focused on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital.
End-to-End Solutions for patient centric care from rapid diagnosis through delivery of personalized therapies
RECENT NEWS
Generex Biotechnology Subsidiary NuGenHealth Contracts with Florida Health Care Associates to Provide Remote Patient Monitoring (RPM) Services
NuGenHealth Software as a Service (SaaS) platform that enables their clients to monitor the health and wellbeing of their patient population. Florida Health Care Associates is a professional corporation that engages medical providers who are duly licensed in...
Generex Provides Clarification on Its Ii-Key COVID-19 Complete Vaccine China Partnership Agreement
MIRAMAR, Fla., May 05, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex” or the “Company”), an innovative and integrated healthcare holding company with end-to-end solutions for patient centric care including the...
GENEREX INVESTOR CALLS
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.